Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised Phase II/III Trial of Preoperative Chemoradiotherapy Versus Preoperative Chemotherapy for Resectable Gastric Cancer

NCT01924819 is registered in ClinicalTrials.gov with Australasian Gastro-Intestinal Trials Group as lead sponsor.

NCT NCT01924819
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01924819 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised Phase II/III Trial of Preoperative Chemoradiotherapy Versus Preoperative Chemotherapy for Resectable Gastric Cancer
Lead sponsor
Australasian Gastro-Intestinal Trials Group
Phase
Phase 2/3
Overall status
Active, not recruiting
Start date
September 30, 2009
Completion date
December 31, 2026
Enrollment
574 (actual)
Sites
59

Conditions

As the registry lists them; a condition with its own page is linked.

gastric cancer